Hermann Haller

Active 1976–2024

Also published as
Hermann HALLER
264
Papers
51,730
Citations
119
h-index
262
i10-index

Citations

Citations per year for Hermann Haller1983: 1 citations1987: 1 citations1990: 2 citations1991: 1 citations1992: 4 citations1993: 3 citations1994: 4 citations1995: 1 citations1996: 10 citations1997: 14 citations1998: 41 citations1999: 69 citations2000: 119 citations2001: 164 citations2002: 223 citations2003: 252 citations2004: 331 citations2005: 406 citations2006: 423 citations2007: 427 citations2008: 362 citations2009: 323 citations2010: 365 citations2011: 394 citations2012: 295 citations2013: 353 citations2014: 288 citations2015: 291 citations2016: 288 citations2017: 264 citations2018: 247 citations2019: 1,191 citations2020: 1,597 citations2021: 1,540 citations2022: 1,226 citations2023: 1,025 citations2024: 1,383 citations2025: 567 citations2026: 14 citations1984–1986: no citations, so these years are not shown1988–1989: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 4,545 citing papers, 20.5% of this breakdownGermany: 1,908 citing papers, 8.6% of this breakdownChina: 1,793 citing papers, 8.1% of this breakdownUnited Kingdom: 1,491 citing papers, 6.7% of this breakdownItaly: 1,167 citing papers, 5.3% of this breakdownFrance: 783 citing papers, 3.5% of this breakdownJapan: 744 citing papers, 3.3% of this breakdownCanada: 715 citing papers, 3.2% of this breakdownNetherlands: 695 citing papers, 3.1% of this breakdownAustralia: 678 citing papers, 3.1% of this breakdownSpain: 678 citing papers, 3% of this breakdownSwitzerland: 523 citing papers, 2.4% of this breakdown
0%20.5%Other 29.2%

Fields

  • Medicine66.7%
  • Biochemistry, Genetics and Molecular Biology20.9%
  • Immunology and Microbiology5.5%
  • Neuroscience2%
  • Nursing1.4%
  • Chemistry0.6%
  • Other2.9%

Topics

  • Blood Pressure and Hypertension Studies4.6%
  • Chronic Kidney Disease and Diabetes2.9%
  • Hormonal Regulation and Hypertension2.3%
  • Renal Diseases and Glomerulopathies2%
  • Diabetes Treatment and Management1.9%
  • Sodium Intake and Health1.6%
  • Other84.7%

Coauthors

All papers

Open in search
  1. 2018 ESC/ESH Guidelines for the management of arterial hypertension

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Anthony M. Heagerty, Stefan Agewall, Murielle Bochud, Claudio Borghi, Pierre Boutouyrie, Jana Brguljan, Héctor Bueno, Enrico G. Caiani, Bo Carlberg, Neil Chapman, Renata Cífková, John G.F. Cleland, Jean-Philippe Collet, Ioan Mircea Coman, Peter W. de Leeuw, Victoria Delgado, Paul Dendale, Hans‐Christoph Diener, Maria Dorobanţu, Robert Fagard, Csaba Farsang, Marc Ferrini, Ian M Graham, Guıdo Grassı, Hermann Haller, F D Richard Hobbs, Bojan Jelakovic, Catriona Jennings, Hugo A Katus, Abraham A Kroon, Christophe Leclercq, Dragan Lovic, Empar Lurbe, Athanasios Manolis, Theresa A McDonagh, Franz H. Messerli, María Lorenza Muiesan, Uwe Nixdorff, Michael Hecht Olsen, Gianfranco Parati, Joep Perk, Massimo Francesco Piepoli, Jorge Polonia, Piotr Ponikowski, Dimitrios J Richter, Stefano F. Rimoldi, Marco Roffi, Naveed Sattar, Petar Seferovic, Iain A Simpson, Miguel Sousa-Uva, Alice Stanton, Philippe van de Borne, Panos E. Vardas, Massimo Volpe, Sven Waßmann, Stephan Windecker, Jose Luis Zamorano, Stephan Windecker, Victor Aboyans, Stefan Agewall, Emanuele Barbato, Héctor Bueno, António Coca, Jean-Philippe Collet, Ioan Mircea Coman, Verónica Dean, Victoria Delgado, Donna Fitzsimons, O. Gaemperli and 111 more - European Heart Journal 2018 cited by 10,433

  2. Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine

    Authors: , , , , , , - European Heart Journal 2020 cited by 579

  3. Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy

    Authors: , , , , , , , , , , , , , , - JAMA 2015 cited by 688

  4. Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Daniel P. Gale, Hermann Haller, Sally Johnson, Mihály Józsi, Diana Karpman, Lynne D. Lanning, Moglie Le Quintrec, Christoph Licht, Chantal Loirat, Francisco Monfort, B. Paul Morgan, Laure-Hélène Noël, Michelle M. O’Shaughnessy, Marion Rabant, Éric Rondeau, Piero Ruggenenti, Neil Sheerin, Jenna L.H. Smith, Fabrizio Spoleti, Joshua M. Thurman, Nicole C. A. J. van de Kar, Marina Vivarelli, Peter F. Zipfel - Kidney International 2016 cited by 695

  5. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , I−Ru Chen, Susan S. Huang, Jin Seok Kim, Gaetano La Manna, Giorgia Comai, Maria Cappuccilli, Moglie Le Quintrec, Guillaume Jeantet, Iino Fumie, Yosu Luque, Jan Menne, J Morelle, Éric Goffin, Anja Mühlfeld, Shashi Nagaraj, Gowthami M. Arepally, Doyeun Oh, Masayoshi Okumi, Manuel Praga Terente, Elena Gutiérrez, Paola Rodrı́guez, François Provôt, Ulf Schönermarck, Michael Fischereder, Natàlia Ramos Terrada, Barbara Seitz‐Polski, Guillaume Favrè, Sonia Boyer‐Suavet, Maria Vinogradova, Tatiana Kirsanova, Edwin Wong - Kidney International 2020 cited by 219

  6. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christiane M. Erley, Karsten Schlieps, Uwe Kuhlmann, Frans Zandvoort, Bernd Hohenstein, Christian Hugo, Catrin Palm, Karl F. Hilgers, Oliver Witzke, Oliver Groß, Ulf Panzer, Hermann Haller, Anna Bertram, Claudia Sommerer, Martin Zeier, Günter Wolf, Martin Busch, Gunter Wolf, Stephan Ziefle, Thomas Benzing, Franziska Grundmann, Peter R. Mertens, Stefan Westphalen, Urs Benck, Uwe Göttmann, Volker Vielhauer, Michael Fischereder, Oliver Sarkar, Marianna Stefanidou, Johannes F.E. Mann, Britta Otte, Hermann Pavenstädt, Bernhard Banas, A Boeger, Nils Heyne, Ferruh Artunç, Helmut Reichel, Thomas Mettang, Christoph Wanner, Thomas Mettang, Stephanie Wied, Christina Fitzner, R.-D Hilgers, Christina Fitzner, R.-D Hilgers - Kidney International 2020 cited by 202

  7. Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: A systematic review and meta-analysis

    Authors: , , , - PLoS Medicine 2019 cited by 194

  8. Heart failure and chronic kidney disease manifestation and mortality risk associations in type 2 diabetes: A large multinational cohort study

    Authors: , , , , , , , , , , , , , , , - Diabetes Obesity and Metabolism 2020 cited by 227

  9. The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , C. David Sjöström, Anna Maria Langkilde, Hiddo J.L. Heerspink - Nephrology Dialysis Transplantation 2020 cited by 190

  10. Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis

    Authors: , , , , , , , , , - British Journal of Haematology 2019 cited by 233

  11. Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes

    Authors: , , , , , , , , , , , , , - Journal of Hypertension 2022 cited by 91

  12. Monocyte chemoattractant protein-1 and the kidney

    Authors: , , , - Current Opinion in Nephrology & Hypertension 2015 cited by 184

  13. Renal Recovery for Patients with ANCA-Associated Vasculitis and Low eGFR in the ADVOCATE Trial of Avacopan

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ben Sprangers, Katherine D. Wissing, Christian Pagnoux, S. Barbour, Soumeya Brachemi, S. Cournoyer, Louis Girard, Louis‐Philippe Laurin, Patrick Liang, David Philibert, Michael Walsh, Vladimı́r Tesař, R. Becvar, P. Horak, Ivan Rychlík, Wladimir Szpirt, Hans Dieperink, Jon Waarst Gregersen, Per Ivarsen, Elizabeth Krarup, Cecilie Lyngsøe, Claire Rigothier, Jean‐François Augusto, Alexandre Bélot, Dominique Chauveau, Divi Cornec, Noémie Jourde‐Chiche, M. Ficheux, Alexandre Karras, Armelle Klein, F. Maurier, Rafik Mesbah, Olivier Moranne, A. Néel, T. Quéméneur, David Saadoun, Benjamin Terrier, Philippe Zaoui, Matthias Schaier, Urs Benck, Raoul Bergner, Matthias H. Busch, Jürgen Floege, Franziska Grundmann, Hermann Haller, Marion Haubitz, B. Hellmich, Jörg Henes, Bernd Hohenstein, C. Hugo, Christof Iking‐Konert, Fabian Arndt, Torsten Kubacki, Ina Kötter, Peter Lamprecht, Tom H. Lindner, Jan Halbritter, H. Mehling, Ulf Schönermarck, Nils Venhoff, Volker Vielhauer, Oliver Witzke, István Szombati, G Szücs, Giacomo Garibotto, Federico Alberici, Enrico Brunetta, Lorenzo Dagna, Salvatore De Vita, Giacomo Emmi and 151 more - Kidney International Reports 2023 cited by 85

  14. Conversion from Calcineurin Inhibitor– to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: A Randomized Phase 3b Trial

    Authors: , , , , , , , , , , , , , , - Journal of the American Society of Nephrology 2021 cited by 99

  15. Loss of vascular endothelial notch signaling promotes spontaneous formation of tertiary lymphoid structures

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2022 cited by 56

  16. Vascular Smooth Muscle Cells Initiate Proliferation of Mesenchymal Stem Cells by Mitochondrial Transfer via Tunneling Nanotubes

    Authors: , , - Stem Cells and Development 2012 cited by 212

  17. Loss of Caveolae, Vascular Dysfunction, and Pulmonary Defects in Caveolin-1 Gene-Disrupted Mice

    Authors: , , , , , , , , , , , , - Science 2001 cited by 1,558

  18. C-C motif-ligand 2 inhibition with emapticap pegol (NOX-E36) in type 2 diabetic patients with albuminuria

    Authors: , , , , , , , , - Nephrology Dialysis Transplantation 2016 cited by 199

  19. Carotid Baroreceptor Stimulation, Sympathetic Activity, Baroreflex Function, and Blood Pressure in Hypertensive Patients

    Authors: , , , , , , , , , , , - Hypertension 2010 cited by 427

  20. Association of osteopontin with kidney function and kidney failure in chronic kidney disease patients: the GCKD study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fruzsina Kotsis, Simone Meder, Erna Mitsch, Ursula Reinhard, Jürgen Floege, Turgay Saritas, Elke Schäeffner, Seema Baid‐Agrawal, Kerstin Theisen, Hermann Haller, Jan Menne, Martin Zeier, Claudia Sommerer, Johanna Theilinger, G Wolf, Martin Busch, Rainer Paul, Thomas Sitter, Christoph Wanner, Vera Krane, Antje Börner-Klein, Britta Bauer, Florian Kronenberg, Julia Raschenberger, Barbara Kollerits, Lukas Forer, Sebastian Schönherr, Hansi Weißensteiner, Peter J. Oefner, Wolfram Gronwald, Matthias Schmid, Jennifer Nadal - Nephrology Dialysis Transplantation 2022 cited by 41

  21. Induction of ferroptosis selectively eliminates senescent tubular cells

    Authors: , , , , , , , , , , , , - American Journal of Transplantation 2022 cited by 46

  22. Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

    Authors: , , , , , , , , , , , , - Journal of Clinical Investigation 1999 cited by 829

  23. Safety and Adequacy of Renal Transplant Protocol Biopsies

    Authors: , , , , , - American Journal of Transplantation 2005 cited by 302

  24. Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice

    Authors: , , , , , , , , , , , , , , , , , , , - Molecular Therapy 2017 cited by 210